RFA-DP-24-031: Epidemiologic Cohort Study of Interstitial Cystitis
Closed
This grant is closed. A newer notice from the same program is forecast: Chronic Disease Education and Awareness (CDC-RFA-DP-27-0068). Status: Expected deadline April 30, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.
Centers for Disease Control and Prevention - ERA offered grants of up to $900,000 (at least $800,000) to any type of organization. It expected to make one award worth $4.2 million in total. Applications closed on February 9, 2024.
From the official notice on Grants.gov, last changed November 15, 2023. Checked November 7, 2026.
- Award ceiling$900,000
- Award floor$800,000
- Total funding$4.2 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 15, 2023 |
|---|---|
| Deadline | February 9, 2024 |
| Archived by Grants.gov | February 11, 2024 |
Who can apply
This opportunity was open to any type of organization.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
This NOFO is open competition
Is this a realistic fit?
- Past Assistance Programs for Chronic Disease Prevention and Control awards averaged $1.0 million; this notice allows up to $900,000 per award.
- Most of the program's money (45% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of the research NOFO is follow a cohort of interstitial cystitis (IC) patients over time, define the demographic and clinical patterns of IC, and document its impact on the health of affected people. In addition, the focus of this NOFO will include translating the scientific knowledge on IC extracted from previously funded and other studies so it can be used to support public health action, including patient strategies for improving quality of life, provider awareness and education, and medical and self-management of IC; strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC.
Who has won Assistance Programs for Chronic Disease Prevention and Control grants before
From fiscal 2021 to 2025, Assistance Programs for Chronic Disease Prevention and Control (93.945) awarded $453 million across 437 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| National Association of Chronic Disease Directors, Inc. | Georgia | 4 | $23.3 million |
| Michigan Department of Health and Human Services | Michigan | 7 | $9.5 million |
| Emory University | Georgia | 4 | $9.4 million |
| Mississippi State Department of Health | Mississippi | 4 | $9.2 million |
| Health Research, Inc. | New York | 7 | $8.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-DP-27-0068, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-DP-24-031 still open?
No. It closed on February 9, 2024. A newer notice is forecast: CDC-RFA-DP-27-0068, expected deadline April 30, 2027.
Who can apply for Epidemiologic Cohort Study of Interstitial Cystitis?
Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Epidemiologic Cohort Study of Interstitial Cystitis?
Closed February 9, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $900,000 each. About $4.2 million in total for one award.
Who has won Assistance Programs for Chronic Disease Prevention and Control grants before?
The largest recipients over five fiscal years were National Association of Chronic Disease Directors, Inc., Michigan Department of Health and Human Services, Emory University. The program made 437 awards worth $453 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)